Search

Julie Ha

Examiner (ID: 17647, Phone: (571)272-5982 , Office: P/1675 )

Most Active Art Unit
1654
Art Unit(s)
1654, 1675
Total Applications
1488
Issued Applications
934
Pending Applications
118
Abandoned Applications
454

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17226988 [patent_doc_number] => 20210353544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-18 [patent_title] => METHOD OF DRUG FORMULATION BASED ON INCREASING THE AFFINITY OF ACTIVE AGENTS FOR CRYSTALLINE MICROPARTICLE SURFACES [patent_app_type] => utility [patent_app_number] => 17/443344 [patent_app_country] => US [patent_app_date] => 2021-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8998 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17443344 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/443344
METHOD OF DRUG FORMULATION BASED ON INCREASING THE AFFINITY OF ACTIVE AGENTS FOR CRYSTALLINE MICROPARTICLE SURFACES Jul 25, 2021 Abandoned
Array ( [id] => 18597235 [patent_doc_number] => 20230272029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-31 [patent_title] => CO-AGONISTS AT GLP-1 AND GIP RECEPTORS SUITABLE FOR ORAL DELIVERY [patent_app_type] => utility [patent_app_number] => 18/017041 [patent_app_country] => US [patent_app_date] => 2021-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15364 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017041 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/017041
CO-AGONISTS AT GLP-1 AND GIP RECEPTORS SUITABLE FOR ORAL DELIVERY Jul 21, 2021 Pending
Array ( [id] => 18724331 [patent_doc_number] => 20230338469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => METHOD OF ENCAPSULATION OF AN ACTIVE PROTEIN USING ELECTRODEPOSITION TECHNIQUES, AN ANTIBACTERIAL COMPOSITION CONTAINING THE ACTIVE PROTEIN AND A POLYMER, AND ITS USE FOR THE PRODUCTION OF MEDICATIONS INTENDED FOR HUMANS [patent_app_type] => utility [patent_app_number] => 18/005052 [patent_app_country] => US [patent_app_date] => 2021-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5512 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005052 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/005052
METHOD OF ENCAPSULATION OF AN ACTIVE PROTEIN USING ELECTRODEPOSITION TECHNIQUES, AN ANTIBACTERIAL COMPOSITION CONTAINING THE ACTIVE PROTEIN AND A POLYMER, AND ITS USE FOR THE PRODUCTION OF MEDICATIONS INTENDED FOR HUMANS Jul 7, 2021 Abandoned
Array ( [id] => 17342171 [patent_doc_number] => 20220008502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => Method to Treat Alzheimer`s Disease [patent_app_type] => utility [patent_app_number] => 17/369681 [patent_app_country] => US [patent_app_date] => 2021-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15984 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17369681 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/369681
Method to treat Alzheimer's disease Jul 6, 2021 Issued
Array ( [id] => 18565725 [patent_doc_number] => 20230256052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => METHOD AND COMPOSITION FOR REDUCING OR PREVENTING BONE RESORPTION [patent_app_type] => utility [patent_app_number] => 18/012288 [patent_app_country] => US [patent_app_date] => 2021-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8539 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18012288 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/012288
METHOD AND COMPOSITION FOR REDUCING OR PREVENTING BONE RESORPTION Jul 6, 2021 Pending
Array ( [id] => 18550631 [patent_doc_number] => 20230248631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-10 [patent_title] => FRAGRANCE RELEASE MECHANISM, METHOD AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/003127 [patent_app_country] => US [patent_app_date] => 2021-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5851 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 209 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18003127 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/003127
FRAGRANCE RELEASE MECHANISM, METHOD AND USES THEREOF Jul 4, 2021 Pending
Array ( [id] => 17336015 [patent_doc_number] => 20220002346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-06 [patent_title] => PEPTIDE-PEPTOID SCAFFOLDS [patent_app_type] => utility [patent_app_number] => 17/366822 [patent_app_country] => US [patent_app_date] => 2021-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8886 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17366822 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/366822
Peptide-peptoid scaffolds Jul 1, 2021 Issued
Array ( [id] => 17299468 [patent_doc_number] => 20210395307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => PEPTIDE THAT REGULATES FAT METABOLISM AND METHOD FOR REGULATING FAT METABOLISM [patent_app_type] => utility [patent_app_number] => 17/359370 [patent_app_country] => US [patent_app_date] => 2021-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7003 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 361 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17359370 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/359370
Peptide that regulates fat metabolism and method for regulating fat metabolism Jun 24, 2021 Issued
Array ( [id] => 19242021 [patent_doc_number] => 12012440 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-18 [patent_title] => Compositions and methods for treatment of fungal infections [patent_app_type] => utility [patent_app_number] => 17/358828 [patent_app_country] => US [patent_app_date] => 2021-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 7006 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17358828 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/358828
Compositions and methods for treatment of fungal infections Jun 24, 2021 Issued
Array ( [id] => 17814330 [patent_doc_number] => 11419919 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-08-23 [patent_title] => High-purity adrenocorticotropic hormone, analogue and a large-scale preparation method thereof [patent_app_type] => utility [patent_app_number] => 17/357255 [patent_app_country] => US [patent_app_date] => 2021-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8330 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17357255 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/357255
High-purity adrenocorticotropic hormone, analogue and a large-scale preparation method thereof Jun 23, 2021 Issued
Array ( [id] => 18860267 [patent_doc_number] => 20230414701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-28 [patent_title] => COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING COGNITIVE DYSFUNCTION DISEASE, COMPRISING PEPTIDE HAVING SYNAPTIC PLASTICITY CONTROL FUNCTION [patent_app_type] => utility [patent_app_number] => 18/011363 [patent_app_country] => US [patent_app_date] => 2021-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5154 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011363 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/011363
COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING COGNITIVE DYSFUNCTION DISEASE, COMPRISING PEPTIDE HAVING SYNAPTIC PLASTICITY CONTROL FUNCTION Jun 17, 2021 Pending
Array ( [id] => 17156115 [patent_doc_number] => 20210317166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-14 [patent_title] => ANTI-INFLAMMATORY USE OF PEPTIDE [patent_app_type] => utility [patent_app_number] => 17/350795 [patent_app_country] => US [patent_app_date] => 2021-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8126 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17350795 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/350795
Anti-inflammatory use of peptide Jun 16, 2021 Issued
Array ( [id] => 19431062 [patent_doc_number] => 20240299560 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-12 [patent_title] => DEOXYCHOLIC ACID-PEPTIDE CONJUGATE HAVING ANTI-OBESITY ACTIVITY AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/009418 [patent_app_country] => US [patent_app_date] => 2021-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7964 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009418 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/009418
DEOXYCHOLIC ACID-PEPTIDE CONJUGATE HAVING ANTI-OBESITY ACTIVITY AND USE THEREOF Jun 10, 2021 Pending
Array ( [id] => 17895269 [patent_doc_number] => 20220304931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-29 [patent_title] => COMPOSITION FOR PROMOTING EXTRACELLULAR VESICLE PRODUCTION CONTAINING PEPTIDE DERIVED FROM NOXA PROTEIN AND METHOD FOR PRODUCING EXTRACELLULAR VESICLES BY USING SAME [patent_app_type] => utility [patent_app_number] => 17/424232 [patent_app_country] => US [patent_app_date] => 2021-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6914 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17424232 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/424232
Composition for promoting extracellular vesicle production containing peptide derived from noxa protein and method for producing extracellular vesicles by using same Jun 2, 2021 Issued
Array ( [id] => 18375975 [patent_doc_number] => 20230151057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-18 [patent_title] => LACTIC ACID BACTERIA GROWTH PROMOTER [patent_app_type] => utility [patent_app_number] => 17/920598 [patent_app_country] => US [patent_app_date] => 2021-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4280 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17920598 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/920598
LACTIC ACID BACTERIA GROWTH PROMOTER May 31, 2021 Pending
Array ( [id] => 18626771 [patent_doc_number] => 20230285578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => PTH ANALOGS FOR THE TREATMENT OF HYPOPARATHYROIDISM [patent_app_type] => utility [patent_app_number] => 17/925477 [patent_app_country] => US [patent_app_date] => 2021-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31107 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17925477 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/925477
PTH ANALOGS FOR THE TREATMENT OF HYPOPARATHYROIDISM May 24, 2021 Pending
Array ( [id] => 18643285 [patent_doc_number] => 11767345 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-26 [patent_title] => Antiviral peptide and use thereof [patent_app_type] => utility [patent_app_number] => 17/329418 [patent_app_country] => US [patent_app_date] => 2021-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 7953 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17329418 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/329418
Antiviral peptide and use thereof May 24, 2021 Issued
Array ( [id] => 18536014 [patent_doc_number] => 20230241101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => THERAPEUTIC COMPOSITION AND METHOD FOR TREATING CORONAVIRUS INFECTION [patent_app_type] => utility [patent_app_number] => 17/927390 [patent_app_country] => US [patent_app_date] => 2021-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11466 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17927390 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/927390
THERAPEUTIC COMPOSITION AND METHOD FOR TREATING CORONAVIRUS INFECTION May 19, 2021 Abandoned
Array ( [id] => 17241810 [patent_doc_number] => 20210361553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-25 [patent_title] => SKIN CARE PRODUCT WITH PROTEIN MATRIX [patent_app_type] => utility [patent_app_number] => 17/323421 [patent_app_country] => US [patent_app_date] => 2021-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6670 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17323421 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/323421
Skin care product with protein matrix May 17, 2021 Issued
Array ( [id] => 18752460 [patent_doc_number] => 20230355711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-09 [patent_title] => VIMENTIN AND FRAGMENTS OR DERIVATIVES THEREOF FOR CORONAVIRUS TREATMENT AND PREVENTION [patent_app_type] => utility [patent_app_number] => 17/998237 [patent_app_country] => US [patent_app_date] => 2021-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19719 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998237 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/998237
VIMENTIN AND FRAGMENTS OR DERIVATIVES THEREOF FOR CORONAVIRUS TREATMENT AND PREVENTION May 13, 2021 Abandoned
Menu